Adverse and Beneficial Functions of Proteolytic Enzymes in Skeletal Muscle
Authors:
- 1 March 2002
- journal article
- review article
- Published by Springer Nature in Adverse Drug Reactions and Toxicological Reviews
- Vol. 21 (1-2) , 31-49
Abstract
Proteolytic enzymes (proteases) comprise a family of enzymes which hydrolyse protein or peptide substrates in the generalised process of intracellular protein degradation, a process essential for the normal functioning of all cells. Proteases may also have a wide range of additional functions, including metabolic control of physiologically active oligopeptides or precursor protein forms, antigen presentation/recognition by the major histocompatibility complex in the cellular immune response, as well as in digestion, blood clotting, complement activation, etc. In this article, the nomenclature and classification of proteolytic enzymes in skeletal muscle, and their role in normal muscle physiological processes have been reviewed, including exercise, muscle development and ageing. Although proteases play an important role in normal muscle functioning, in pathological situations the enzymes may themselves be regarded as ‘toxic agents’ in terms of their damaging effects on muscle tissue. Muscle damage resulting from inappropriate activity of proteolytic enzymes in muscle wasting associated with muscular dystrophies, denervation atrophy, inflammatory myopathies, cancer, sepsis, diabetes and alcoholism have been reviewed. In addition, evidence that the adverse effects of drugs known to induce muscle wasting, such as corticosteroids, (or beneficial effects of growth promoting drugs) may be mediated via proteolytic enzymes is also reviewed.Keywords
This publication has 97 references indexed in Scilit:
- Delay of muscle degeneration and necrosis in mdx mice by calpain inhibitionMuscle & Nerve, 1999
- Activation of Caspase-3 Apoptotic Pathways in Skeletal Muscle Fibers in Laminin α2-Deficient MiceBiochemical and Biophysical Research Communications, 1999
- Glucocorticoids Do Not Regulate the Expression of Proteolytic Genes in Skeletal Muscle from Cushing's Syndrome PatientsThe Journal of Clinical Endocrinology & Metabolism, 1997
- Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy menThe Journal of Clinical Endocrinology & Metabolism, 1996
- Muscle aspartyl protease (cathepsin D) activity: detection using a chromophoric substrate and relation to wasting in DBA/2 mice implanted with leukemic L1210 tumor cellsCanadian Journal of Physiology and Pharmacology, 1996
- Stabilisation of neuromuscular junctions by leupeptin increases motor unit size in partially denervated rat musclesDevelopmental Brain Research, 1995
- Muscle Undergoes Atrophy in Association with Increase of Lysosomal Cathepsin Activity in Interleukin-6 Transgenic MouseBiochemical and Biophysical Research Communications, 1995
- Effect of denervation on overdevelopment of chloroquine‐induced autophagic vacuoles in skeletal musclesMuscle & Nerve, 1993
- Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular DystrophyNew England Journal of Medicine, 1989
- Specificity of neuropeptide degradation by two calcium-activated neutral proteases from human skeletal muscleLife Sciences, 1985